Relationship Between Carotid Intima-Media Thickness with some Inflammatory Biomarkers, Ghrelin and Adiponectin in Iranians with and without Metabolic Syndrome in Isfahan Cohort Study by Hajmohammadi, Taiebeh et al.
 
1- Resident of Cardiology, Isfahan University of Medical Sciences 
2- Associate Professor of Cardiology, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 
3- Resident of Neurology, Isfahan University of Medical Sciences 
4- Associate Professor of Cardiology, Isfahan University of Medical Sciences 
5- Associate Professor of Neurology, Isfahan University of Medical Sciences 
6- General Practitoner, Medical Researcher 
7- Medical doctor, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 
8- Professor of Cardiology, Head of Isfahan Cardiovascular Research Center, Isfahan 
Corresponding to: Masoudmeh Sadeghi, Email: Sadeghimasoumeh@gmail.com 
 
    ARYA Atherosclerosis Journal 2010 (Summer); Volume 6, Issue 2  56 
RELATIONSHIP BETWEEN CAROTID INTIMA-MEDIA THICKNESS WITH 
SOME INFLAMMATORY BIOMARKERS, GHRELIN AND ADIPONECTIN 
IN IRANIANS WITH AND WITHOUT METABOLIC SYNDROME IN  
ISFAHAN COHORT STUDY 
Taiebeh Hajmohammadi 
(1), Masoumeh Sadeghi 
(2), Masoumeh Dashti 
(3), Mohammad Ha-
shemi 
(4), Mohammad Saadatnia 
(5), Mojgan Soghrati 
(6), Mohammad Talaei 
(7), Nizal Sarraf-
zadegan 
(8) 
 
Abstract 
  BACKGROUND: Recent studies have confirmed inflammatory factors and metabolic syndrome 
(MetS) as important cardiovascular disease (CVD) risk factors. Recently measurement of carotid 
intima-media thickness (IMT) has been used for evaluation of early atherosclerosis. This study 
was designed to assess the correlation between IMT with some inflammatory biomarkers, ghre-
lin and adiponectin in people with and without MetS in a cohort sample in Isfahan province. 
  METHODS: Among participants of Isfahan Cohort Study (ICS) by random sampling, 88 partic-
ipants were selected and divided into case (with MetS) and control (without MetS) groups. A 
questionnaire including demographic data and CVD risk factors was completed for all of the 
participants. Physical examination and blood pressure, height, weight and waist circumference 
measurements were done for all subjects. Vascular echocardiography was done for evaluation of 
IMT of each carotid artery of both sides. Interlukin-6 (IL-6), interlukin-10 (IL-10), highly sensi-
tive C-reactive protein (hs-CRP), ghrelin and adiponectin levels were measured using ELIZA 
method. Data were entered in SPSS15 software and analyzed by t-test, chi square, Pearson corre-
lation and linear regression analyze. 
  RESULTS: The mean waist circumference, BMI, systolic blood pressure, diastolic blood pres-
sure, hs–CRP and IMT of left carotid artery were significantly higher in participants with Mets. 
There  was  significant  correlation  between  left  carotid  IMT  and  IL-6  level  in  all  patients  
(P = 0.03). After adjustment for age and sex, significant relationship in groups with MetS was only 
reported between the left IMT and IL-6 (P = 0.02). There was no relation between IMT and oth-
er inflammatory markers in subjects with and without MetS. 
  CONCLUSION: Significant correlation between IL-6 and IMT was reported in patients with 
MetS. While no significant correlation between IL-10, adiponectin and ghrelin with IMT was ob-
served in metabolic syndrome group. 
 
Keywords: Intima-media thickness (IMT), Carotid artery, hs-CRP, Ghrelin, Adiponectin IL-6, 
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Introduction 
Metabolic syndrome (MetS) is defined as the accumu 
lation of several cardiovascular risk factors (CVD) in 
an individual including visceral obesity, hypertension, 
high triglyceride (TG) level, low level of high density–
lipoprotein  cholesterol  (HDL C)  and  impaired  glu 
cose tolerance test.1 The prevalence of MetS in Iran 
has  been  estimated  as  23.3%  which  is  higher  than   T . Hajmohammadi, M. Sadeghi, M. Dashti, M. Hashemi, M. Saadatnia, M. Soghrati, M. Talaei, N. Sarrafzadegan 
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some of the western countries2 and based on increas 
ing prevalence of obesity in children and adolescents 
in Iran, prevalence of MetS will be increased in the 
future.3 Nowadays, despite various preventive modali 
ties for CVD, it is still increasing, so screening for 
high risk individuals and using preventive methods is 
very important.4 
  Beside  main  risk  factors  of  CVD  like  hyperten 
sion,  diabetes,  smoking  and  hyperlipidemia,  recent 
studies have confirmed inflammatory factors and me 
tabolic  syndrome  as  important  CVD  risk  factors.5,6 
Increase in C reactive protein (CRP) level which is an 
inflammatory marker, is an independent predictor of 
CVD and an important factor in progression of me 
tabolic  syndrome.4 6  Correlation  between  CRP  and 
subclinical atherosclerosis is not fully understood but 
two  studies  reported  positive  relationship  between 
CRP and carotid plaque and another study has shown 
that correlation between CRP and carotid plaque de 
pends on the degree of stenosis and severity of athe 
rosclerosis.7,8  Makita  et  al  study  showed  significant 
correlation between CRP and carotid plaque only in 
men.8 Studies showed that the serum level of two in 
flammatory factors, interleukin 6 and interleukin 10, 
are related to the increase in prevalence of CVD.5,9 
Also, lower serum level of adiponectin (a specific ob 
esity  factor)  has  been  suggested  as  an  independent 
risk factor for CVD.10 Ghrelin is a marker of endo 
thelial function which produces nitric oxide (NO) in 
the endothelial cells of the vessels. Lower serum le 
vels of ghrelin have significant relationship with insu 
lin resistance, type II diabetes and hypertension that 
leads  to  increase  in  atherosclerosis.11,12  Few  studies 
have been done on the effect of ghrelin on atheros 
clerosis  in  MetS  and  some  of  the  studies  have  re 
ported  the  reverse  correlation  between  ghrelin  and 
atherosclerosis.13,14 Recently, measurement of carotid 
intima media thickness (IMT) using ultrasonography 
as a non invasive method has been used for evalua 
tion of vascular damage but few studies have assessed 
the  effect  of  metabolic  syndrome  on  carotid  artery 
IMT.15 It seems that assessment of the relationship 
between carotid IMT and some inflammatory factors, 
ghrelin and adiponectin in MetS, may predict asymp 
tomatic vascular changes in patients with MetS. This 
study was designed to assess the correlation between 
carotid  IMT  with  some  inflammatory  biomarkers, 
ghrelin and adiponectin in people with and without 
MetS in sample of cohort in Isfahan province. 
Materials and methods 
This study was a done on a sample of Isfahan Cohort 
Study (ICS) participants. ICS has been started since 8 
years ago (2001) as a part of baseline study of Isfahan 
Healthy Heart Program (IHHP).16 Participants ≥ 35 
years that were selected via multi stage cluster sam 
pling from phase I of IHHP were included in ICS. 
Demographic  and  behavioral  characteristics,  blood 
pressure, body mass index(BMI) and routine labora 
tory tests like fasting blood sugar (FBS), 2 hour post 
prandial  sugar,  total  cholesterol,  LDL cholesterol 
(LDL C),  HDL cholesterol  (HDL C),  triglyceride 
(TG)  and  electrocardiography  for  all  of  the  partici 
pants were done and recorded at the first year of ICS. 
Then, every 2 years, each of the participants was fol 
lowed by phone for assessment of primary outcomes 
of this cohort that included fatal or non-fatal myo-
cardial  infarction,  fatal  or  non fatal  stroke,  sudden 
cardiac death and hospitalization. In 2007, the tests 
and measurements were repeated again.17 Among 599 
(39.4%) ICS participants in Isfahan (rural and urban) 
who suffered from MetS and remained in the study 
(not  missed  the  follow–ups),  350  (58.4%)  patients 
were randomly selected. The same number of subjects 
were selected from the rest of population (921) who 
did  not  have  MetS  (38%).  Fifteen  participants  had 
died  since  the  last  follow  up.  On  the  whole,  472 
(68.9%) attended the examinations. IMT test and la 
boratory  measurements  were  carried  out  for  a  ran 
domly  selected  sub sample  of  this  population  con 
sisted of 44 patients with MetS and 44 participants 
without it. Random selection procedures were done 
via  random  sampling  (Sampling  Wizard)  in  SPSS15 
software.  According  to  ATPIII  criteria,  metabolic 
syndrome is defined as having at least three of the 
five criteria: 1  waist circumference > 102cm in men 
and  >88  cm  in  women,  2   serum  triglyceride  > 
150mg/dl, 3  HDL<40 mg/dl in men and < 50mg/dl 
in women, 4  FBS > 110 mg/dl, 5  Blood pressure > 
130/85 mmHg.18 Inclusion criteria were the follow 
ings: participating in ICS from 2001 with ATPIII cri 
teria for Mets.18 Exclusion criteria were the follow 
ings: participant’s dissatisfaction, history of stroke or 
other cerebrovascular problems, pregnancy, history of 
carotid operation or carotid stent. The case and con 
trol group’s questionnaires were assessed and patients 
who  didn’t  have  exclusion  criteria  were  invited  via 
telephone  call.  Written  informed  consent  was  ob 
tained from all participants. A questionnaire including 
demographic  data,  CVD  risk  factors,  history  of  di 
abetes,  hypertension,  smoking,  hyperlipidemia  and 
duration  of  these  disease  and  all  of  the  previous 
treatments, was completed for all participants in both 
case and control groups. Physical examination includ 
ing blood pressure, height, weight and waist circumfe 
rence measurements was done for all subjects using 
standard  methods.19  Ten  milliliter  of  fasting  blood CAROTID INTIMA MEDIA THICKNESS (IMT), INFLAMMATORY BIOMARKERS AND METABOLIC SYNDROME  
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was obtained from the participants and sent to the 
laboratory of Isfahan Cardiovascular Research Center 
and after centrifuge, was preserved at  70 degrees of 
centigrade for necessary laboratory tests (ghrelin, in 
terleukin 6 and 10, adiponectin and hs CRP). Ghrelin 
was measured using ELISA method and BioVendor 
kits.  Then,  all  subjects  in  both  case  and  control 
groups  underwent  vascular  echocardiography  for 
evaluation of carotid IMT. Carotid IMT was meas 
ured by a neurologist using Vivid 3 echocardiograph 
(Vivid  3 Japan)  in  both  carotid  arteries  in  three 
points: 1  terminal 2 cm of common carotid artery 
before the division of carotid flow, 2  carotid bulb in 
2 cm from the part of carotid division, 3  internal ca 
rotid artery, 2 cm after carotid division. Normal caro 
tid IMT is < 0.9 mm and between 0.9 1.5 mm is con 
sidered abnormal. IL 6 and IL 10 were measured via 
ELIZA  method  using  Medsystem  kit  (Bendermed 
Austria). Adiponectin and ghrelin were measured via 
ELIZA method, using Biovendor kit (Germany) and 
hs CRP was measured via immunoturbidimetry me 
thod with Autoanalyzer (Hitachi 902) with Pars Az 
mun kit (Iran). Data were analyzed via SPSS15 soft 
ware with t test, ANOVA and chi Square for compar 
ison  between  the  two  groups  and  linear  regression 
models and Pearson correlation for finding relation 
between variables.  
Results 
  Eighty eight subjects were enrolled in this study 
and were divided into case and control groups with 44 
subjects in each group. Clinical and biological charac 
teristics of the study subjects are summarized in Table 
1. The mean waist circumference (P = 0.001), BMI  
(P = 0.00), systolic blood pressure (P = 0.001), diastolic 
blood pressure (P = 0.001), hs–CRP (P = 0.006) and 
IMT of left carotid artery (P = 0.02) were significantly 
higher in participants with metabolic syndrome (case 
group,  Table  1).  Subjects  with  metabolic  syndrome 
had significantly higher percentage of non smokers or 
previously smokers compared with the control group 
(P  =  0.02).  No  significant  difference  was  reported 
between the two groups in mean age, FBS, total cho 
lesterol, LDL–C, HDL C, interlukin 6, interlukin 10, 
adiponectin, ghrelin and IMT of right carotid artery 
(Table 1). As it is shown in table 2, there was a signif 
icant correlation between mean left carotid IMT and 
IL 6 level in all patients (p = 0.035) and there was not 
any correlation between IMT and IL 10, adiponectin, 
ghrelin and hs CRP. As it has been shown in table 3, 
after adjustment for age and sex, significant relation 
ship in groups with MetS was only reported between 
left IMT and IL 6 (P = 0.02).  
 
Discussion 
Results of the current study showed significant corre 
lation between metabolic syndrome and female sex, 
BMI, hs CRP and left carotid artery IMT (P < 0.05). 
Although our results showed significant relationship 
between  IL 6  level  and  right  carotid  artery IMT  in 
patients with MetS, in this study IMT showed signifi 
cant correlation with hs CRP level in patients without 
MetS too. No significant correlation between IL 10, 
adiponectin and ghrelin with IMT in metabolic syn 
drome  was  observed  in  this  study.  The  correlation 
between CRP and subclinical atherosclerosis isn’t fully 
understood yet but Willeit et al and Heinrich et al re 
ported  positive  relationship  between  CRP  and  the 
presence of carotid plaques. Willeit et al study showed 
that this correlation depends on the degree of stenosis 
and the severity of atherosclerosis.20,21 In Willeit et al 
study,  significant  relationship  was  seen
Table 1. Baseline clinical and laboratory characteristics of participants with or without metabolic syndrome. 
 
Demographic  
Characteristics 
Subjects with  
metabolic syndrome 
Subjects without  
metabolic syndrome  P value 
Age (years) 
Smoking status (n.%) 
Never and past 
Current 
Male sex (n,%) 
BMI (Kg/m
2) 
IL-6(pg/ml) 
IL-10 (pg/ml) 
Adiponectin (µg/ml) 
Ghrelin (µg/ml) 
hs-CRP (µg/ml) 
Mean IMT. Rt (mm) 
Mean IMT. Lt (mm) 
55.63±8.6 
 
 
6.8 
15(34.1%) 
30.71±6.2 
0.90±0.69 
1.06±1.1 
14.25±10 
106.53±66 
20.12±25 
0.73±0.14 
0.77±0.19 
52.86±7.6 
 
93.2 
25 
29(65.9%) 
26.00±3.7 
0.76±0.49 
1.28±1.2 
14.46±10 
135.24 ±84 
7.70±10 
0.68±0.12 
0.68±0.14 
0.11 
 
75 
0.02 
0.003 
0.000 
0.29 
0.40 
0.92 
0.09 
0.006 
0.09 
0.02   T . Hajmohammadi, M. Sadeghi, M. Dashti, M. Hashemi, M. Saadatnia, M. Soghrati, M. Talaei, N. Sarrafzadegan 
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Values are mean (SD). BMI: body mass index,IL-6:interleukin 6,IL-10:interleukin 10,hs-CRP:high sensitive CRP, IMT: intima-
media thickness. 
Table 2. Relation between mean IMT and inflammatory markers in all subjects. 
 
 
IL- 6  IL- 10  Adiponectin  Ghrelin  hs- CRP 
B  P  B  P  B  P  B  P  B  P 
Mean IMT. Rt  -0.12  0.25  0.038  0.72  -0.07  0.46  -0.029  0.78  -0.21  0.07 
Mean IMT. Lt  -0.19  0.035  0.20  0.058  -0.16  0.08  -0.15  0.09  -0.14  0.17 
Adjusted by age, sex, Mets. 
 
between CRP level with early nonstenotic atheroscle 
rosis (equal or less than 40% narrowing of the lumen) 
not  with    advanced  stenotic  atherosclerosis  (more 
than 40% narrowing of the lumen).21 Makita et al8 and 
Chen  et  al4  showed  significant  correlation  between 
CRP and carotid plaque only in men. Elevated CRP 
level has been found in metabolic syndrome.22 In our 
study,  although  the  relationship  between  CRP  and 
Mets  was  significant,  its  relationship  with  IMT  in 
Mets participants wasn't significant and CRP had sig 
nificant relationship with IMT in participants without 
Mets  which  is  different  from  the  results  of  several 
studies that have reported significant correlation be 
tween  hs CRP  and  IMT  in  MetS.4  The  absence  of 
correlation between CRP and IMT in MetS partici 
pants in our study may be due to higher frequency of 
MetS in female sex compared with Makita et al8 and 
Chen et al4 studies which reported significant correla 
tion between CRP and carotid plaque, only in men. 
Even more, our subjects had advanced stenotic athe 
rosclerosis (more than 40% narrowing of the lumen) 
and according to Willeit et al study, advanced stenotic 
atherosclerosis  has  no  correlation  with  CRP  level.21 
Tracy et al7 and Nishida et al5 did not find any corre 
lation between CRP and IMT. Tataru et al didn’t re 
port any relationship between CRP and nonstenotic 
plaques (<50%) in patients with coronary heart dis 
ease23 Our results are close to Tracy et al7 and Nishida 
et al5 studies but different than Tataru et al23 study. 
This may be explained by the presence of advanced 
stenotic lesion in our subjects. We reported significant 
relationship  between  IL 6  and  right  carotid  artery 
IMT in patients with MetS (P = 0.004). Nishida et al 
showed  significant  relationship  between  IL 6  and 
IMT only in men with MetS.5 We could not find any 
previous study on the relationship between IL 10 and 
IMT in MetS. In our study, no correlation between 
IMT and adiponectin was observed which is different 
than Nishida et al study that has shown negative cor 
relation between IMT and adiponectin in men;5 this 
difference may be due to inclusion of more women 
with metabolic syndrome in our study sample. Dul 
laart  et  al  study  showed  significant  relationship  be 
tween adiponectin and IMT too.24 We didn’t find any 
significant positive or negative relationship between 
IMT and ghrelin in patients with metabolic syndrome. 
Ukkola  et  al  reported  positive  correlation  between 
ghrelin and IMT in Mets(P < 0.01).25 Some studies 
have reported reverse correlation between ghrelin and 
atherosclerosis.13,14  In  summary,  this  study  showed 
significant relationship between IL 6 and right coro 
nary artery IMT in patients with MetS and significant 
correlation between IMT and hs CRP level in patients 
without metabolic syndrome. No significant correla 
tion  between  IL 10,  adiponectin  and  ghrelin  with 
IMT in MetS was observed in this study. The limita 
tions of the present study included the small sample 
size and its design as a cross sectional study which 
didn't enable any casual relationship to be established. 
Further  investigations  with  large  sample  size  and 
longer duration especially on ghrelin, adiponectin and 
IL 10 are necessary.  
 
Table 3. Relation between IMT and inflammatory markers in participants with and without metabolic syndrome. 
 
Groups 
IL-6  IL-10  Adiponectin  Ghrelin  hs-CRP 
B coefficient    p  B coefficient    p  B coefficient       p  B coefficient     p  B coefficient       p 
Mean IMT.Rt     MetS(+) 
                      MetS(-) 
 
Mean IMT.Lt     MetS(+) 
                      MetS(-) 
 
-0.234           0.12 
0.140            0.40 
 
-0.249           0.04 
 0.057           0.72    
 
-0.106            0.45 
0.198             0.22 
 
-0.075            0.55 
0.172             0.28 
-0.149              0.29 
0.011               0.94 
 
-0.113              0.36 
-0.227              0.12 
 
-0.307            0.26 
0.252              0.09         
 
-0.193            0.12 
-0.159            0.28 
 
-0.123              0.43 
-0.36                0.02 
 
-0.071              0.61 
-0.258              0.09 
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